argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced its third quarter 2023 financial results and provided a business update and outlook for the remainder of the year.
argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced its third quarter 2023 financial results and provided a business update and outlook for the remainder of the year.